44 related articles for article (PubMed ID: 18929649)
1. In vivo investigation of tolerance and antitumor activity of cisplatin-loaded PLGA-mPEG nanoparticles.
Mattheolabakis G; Taoufik E; Haralambous S; Roberts ML; Avgoustakis K
Eur J Pharm Biopharm; 2009 Feb; 71(2):190-5. PubMed ID: 18929649
[TBL] [Abstract][Full Text] [Related]
2. Beyond chemotherapeutics: cisplatin as a temporary buckle to fabricate drug-loaded nanogels.
Zhang W; Zhang Z; Tung CH
Chem Commun (Camb); 2017 Jan; 53(4):779-782. PubMed ID: 27999837
[TBL] [Abstract][Full Text] [Related]
3. In vivo efficacy of nano hyaluronan-conjugated cisplatin for treatment of murine melanoma.
Yang Q; Aires DJ; Cai S; Fraga GR; Zhang D; Li CZ; Forrest ML
J Drugs Dermatol; 2014 Mar; 13(3):283-7. PubMed ID: 24595572
[TBL] [Abstract][Full Text] [Related]
4. PEGylated Polymeric Nanoparticles Loaded with 2-Methoxyestradiol for the Treatment of Uterine Leiomyoma in a Patient-Derived Xenograft Mouse Model.
Enazy SA; Kirschen GW; Vincent K; Yang J; Saada J; Shah M; Oberhauser AF; Bujalowski PJ; Motamedi M; Salama SA; Kilic G; Rytting E; Borahay MA
J Pharm Sci; 2023 Sep; 112(9):2552-2560. PubMed ID: 37482124
[TBL] [Abstract][Full Text] [Related]
5. Enhancing Therapeutic Efficacy against
Hernández-Giottonini KY; Arellano-Reynoso B; Rodríguez-Córdova RJ; de la Vega-Olivas J; Díaz-Aparicio E; Lucero-Acuña A
ACS Omega; 2023 Dec; 8(51):49362-49371. PubMed ID: 38162745
[TBL] [Abstract][Full Text] [Related]
6. Corrigendum: Treatment of surgical brain injury by immune tolerance induced by peripheral intravenous injection of biotargeting nanoparticles loaded with brain antigens.
Tian Z; Xu L; Chen Q; Feng R; Lu H; Tan H; Kang J; Wang Y; Yan H
Front Immunol; 2023; 14():1335541. PubMed ID: 38143755
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.
Danhier F; Lecouturier N; Vroman B; Jérôme C; Marchand-Brynaert J; Feron O; Préat V
J Control Release; 2009 Jan; 133(1):11-7. PubMed ID: 18950666
[TBL] [Abstract][Full Text] [Related]
8. Environmentally Friendly Strategies for Formulating Vegetable Oil-Based Nanoparticles for Anticancer Medicine.
Freire N; Barbosa RM; García-Villén F; Viseras C; Perioli L; Fialho R; Albuquerque E
Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514094
[TBL] [Abstract][Full Text] [Related]
9. Platinum-Based Nanoformulations for Glioblastoma Treatment: The Resurgence of Platinum Drugs?
Alfonso-Triguero P; Lorenzo J; Candiota AP; Arús C; Ruiz-Molina D; Novio F
Nanomaterials (Basel); 2023 May; 13(10):. PubMed ID: 37242036
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity towards Breast Cancer Cells of Pluronic F-127/Hyaluronic Acid Hydrogel Containing Nitric Oxide Donor and Silica Nanoparticles Loaded with Cisplatin.
de Melo Santana B; Pieretti JC; Gomes RN; Cerchiaro G; Seabra AB
Pharmaceutics; 2022 Dec; 14(12):. PubMed ID: 36559330
[TBL] [Abstract][Full Text] [Related]
11. Poly(Lactic Acid)-Based Microparticles for Drug Delivery Applications: An Overview of Recent Advances.
Vlachopoulos A; Karlioti G; Balla E; Daniilidis V; Kalamas T; Stefanidou M; Bikiaris ND; Christodoulou E; Koumentakou I; Karavas E; Bikiaris DN
Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214091
[TBL] [Abstract][Full Text] [Related]
12. A Tri-Stimuli Responsive (Maghemite/PLGA)/Chitosan Nanostructure with Promising Applications in Lung Cancer.
Fernández-Álvarez F; García-García G; Arias JL
Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452193
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles of cisplatin augment drug accumulations and inhibit multidrug resistance transporters in human glioblastoma cells.
Maliyakkal N; Appadath Beeran A; Udupa N
Saudi Pharm J; 2021 Aug; 29(8):857-873. PubMed ID: 34408546
[TBL] [Abstract][Full Text] [Related]
14. Nanomedicines in the treatment of colon cancer: a focus on metallodrugs.
Farinha P; Pinho JO; Matias M; Gaspar MM
Drug Deliv Transl Res; 2022 Jan; 12(1):49-66. PubMed ID: 33616870
[TBL] [Abstract][Full Text] [Related]
15. Development, optimization, and evaluation of PEGylated brucine-loaded PLGA nanoparticles.
Elsewedy HS; Dhubiab BEA; Mahdy MA; Elnahas HM
Drug Deliv; 2020 Dec; 27(1):1134-1146. PubMed ID: 32729331
[TBL] [Abstract][Full Text] [Related]
16. Transferrin-Conjugated Docetaxel-PLGA Nanoparticles for Tumor Targeting: Influence on MCF-7 Cell Cycle.
Jose S; A CT; Sebastian R; H SM; A AN; Durazzo A; Lucarini M; Santini A; Souto EB
Polymers (Basel); 2019 Nov; 11(11):. PubMed ID: 31752417
[TBL] [Abstract][Full Text] [Related]
17. Recent Progress in the Development of Poly(lactic-
Kim KT; Lee JY; Kim DD; Yoon IS; Cho HJ
Pharmaceutics; 2019 Jun; 11(6):. PubMed ID: 31197096
[TBL] [Abstract][Full Text] [Related]
18. PEGylation: a promising strategy to overcome challenges to cancer-targeted nanomedicines: a review of challenges to clinical transition and promising resolution.
Hussain Z; Khan S; Imran M; Sohail M; Shah SWA; de Matas M
Drug Deliv Transl Res; 2019 Jun; 9(3):721-734. PubMed ID: 30895453
[TBL] [Abstract][Full Text] [Related]
19. PLGA-Based Nanoparticles in Cancer Treatment.
Rezvantalab S; Drude NI; Moraveji MK; Güvener N; Koons EK; Shi Y; Lammers T; Kiessling F
Front Pharmacol; 2018; 9():1260. PubMed ID: 30450050
[TBL] [Abstract][Full Text] [Related]
20. Renoprotective Effect of Platelet-Rich Plasma on Cisplatin-Induced Nephrotoxicity in Rats.
Salem N; Helmi N; Assaf N
Oxid Med Cell Longev; 2018; 2018():9658230. PubMed ID: 30116500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
